Business
Onco-Innovations Chairs Colorectal Cancer Canada Precision Oncology Forum Generating Roadmaps for the Next Era of Cancer Care
VANCOUVER, BC / ACCESS Newswire / December 9, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is pleased to announce, further to its news release dated September 12, 2025, the completion ...
About this update from Onco-innovations Ltd.
[{"type":"text","content":"VANCOUVER, BC / ACCESS Newswire / December 9, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is pleased to announce, further to its news release dated September 12, 2025, the completion of the fourth session in Colorectal Cancer Canada's Catalysts: Innovating for Tomorrow Series, led by its subsidiary, Inka Health Corp. ("Inka Health" or "Inka"). The invitation-only virtual roundtable, titled Beyond Borders: Data-Driven Innovation for Global Precision Oncology, held on December 2, 2025, brought together approximately 20 senior leaders from across the oncology ecosystem, including representatives from industry, government, academic medicine, and leading clinical programs, for a highly interactive and action-oriented discussion focused on accelerating national progress in precision oncology.","length":911,"tagName":"p"},{"type":"text","content":"The roundtable, chaired by Dr. Paul Arora, Co-founder of Onco-Innovations' subsidiary Inka Health, featured opening remarks from Colorectal Cancer Canada (CCC) President and CEO Barry D. Stein, followed by framing insights from Series Chair Dr. Lilian Siu of the Princess Margaret Cancer Centre.","length":299,"tagName":"p"},{"type":"text","content":"Throughout the two-and-a-half-hour session, participants engaged in a series of thematic discussions addressing critical enablers of next-generation cancer care. Presentations by Dr. Steven Jones of BC Cancer, Dr. Alind Gupta of Inka Health, and Dr. Winson Cheung of the University of Calgary explored the current state of precision medicine in Canada, the importance of transportable evidence and causal inference for global clinical adoption, and the growing role of new data sources, including patient support program information and synthetic data, in real-world oncology research. These topics were examined through the lens of national scalability, data governance, interoperability, and the practical frameworks required to translate technical advancements into routine clinical benefit.","length":794,"tagName":"p"},{"type":"text","content":"The roundtable also featured structured breakout groups and a collaborative synthesis session designed to generate concrete actions that will inform an upcoming publication outlining CCC's visio...